$SFLM Overview - As At July 23

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
234
$SFLM Overview - As At July 23 2023

Changes In This Update

- Share Structure Section:

-- July 20, 2023 update incorporated - no change - no dilution.

-- Days since no change - no dilution to Unrestricted Outstanding Shares updated - now 264 to July 23, 2023.

Backstory

- From October 2020 to November 2022, SFLMaven Corp - ticker $SFLM [formerly $SKDI to March 2021] - comprised only the wholly owned subsidiary SFLMaven of Florida, LLC - a Top Rated eBay seller of jewelry in business for 19+ years.

- Despite SFLMaven of Florida, LLC increasing gross revenue by 35% in 2021 over 2020 - and being on track for a further 15%>20% increase in 2022, it was still operating at a net loss in 2022 Q3 after taking into account large past adjustments for eBay seller's fees in earlier backdated periods.

"New" SFLMaven Corp [$SFLM] - Effective November 15, 2022 Onwards

On November 15, 2022, it was PR'ed that:

- Chad MacKay had been appointed as Chairman and CEO of SFLMaven Corp [replacing Joe Ladin].

- He will oversee the launch of the Company’s new business plan that focuses on acquisitions or technology licensing opportunities.

- The Company will focus on identifying companies and/or technologies that could be impactful in their respective industries.

- Chad MacKay is the co-founder and managing partner of Loyal Companies, a private equity firm focusing on mergers and acquisitions.

- The Company’s previous Chairman and CEO, Joseph Ladin, resigned as Chairman and CEO as part of these changes.

- SFLMaven Corp decided to divest of its operating subsidiary, SFLMaven of Florida, LLC and this was completed as planned in November 2022.

- The 2022 Annual Report was filed on April 17, 2023 signed by the new CEO.

- The $SFLM record with WYSOS was updated on May 12, 2023 showing:

-- Now Active - Current.

-- Upgraded to in Good Standing for Tax and all other categories.

-- Changed the registered Principal Office address to Salt Lake City, UT after divesting the previous loss-making business in FL.

- The $SFLM record at otcmarkets.com started to get updated on June 30, 2023, as follows:

-- New HQ address in UT: now 12884 S Frontrunner Blvd, Draper, UT 84020.

--- Interior views of the upscale corporate workspace suites in this building here:

https://d3vfz99dlfnk1r.cloudfront.net/uploads...397477.jpg

https://d3vfz99dlfnk1r.cloudfront.net/uploads...65b551.jpg

- Phone update: now +1 801-808-7614

- Chad MacKay added as CEO, CFO and Sec.

- Email updated: chad@loyalcompanies.com

- Website for divested subsidiary SFL Maven of FL removed.

$SFLM CEO - Chad MacKay

- Prior to joining Loyal Companies, Chad MacKay was founder and managing partner of Kai Data Companies.

- He has been actively involved as a director with other companies and organizations. Among the boards on which he serves currently and in the past are: Loyal Companies, Revvu, Cumulus, Cumulus Advanced Technologies, Kai Data, Vulcan7, Espresso Agent, Team Leads, Bear River Management Group, Kai Insurance, Synergy Holdings, RAD, Loyal Technologies, Trustee for Chase N' Heaven and Brother's Keeper.

- In the November 15, 2022 PR he stated:

- “I am very excited to become a part of SFLMaven Corp as the Company’s Chairman and CEO."

- "I have been in private equity for the past 15 years and have done a lot of exciting deals."

- "Our team has built an impressive deal flow of prospects that c ould be acquired or technology that could be licensed by SFLM.”

- “Our goal will be to add acquisitions and/or licensing agreements to technologies that we believe will be accretive to the Company and our Shareholders. For example, we are working with one credible University on some amazing technologies in the lithium mining industry that could be really important to the future of electric batteries."

- "Where it makes sense to focus on specific verticals, we will. If we find Companies that could benefit by being a part of the SFLM family of companies we will evaluate those.

- "We have an aggressive team and look forward providing more detailed updates in the near future.”

$SFLM CEO Linkedin Profile:

https://www.linkedin.com/in/chad-mackay-2b3417156

Loyal Companies website: https://www.loyalcompanies.com/

"New" $SFLM PRs Since November 15, 2022

Ongoing PR campaign with 1 release to date.

News - November 15. SFLMaven Corp. Announces the Appointment of Chad MacKay as Chairman and CEO and Announces New Business Plan.

https://www.otcmarkets.com/stock/SFLM/news/SF...?id=380331

2022 Annual Report

Confirmed that:

- The loss-making subsidiary SFL Maven of Florida LLC had been divested as planned in November 2022.

- The new business direction was still as described in the last PR - technology licensing and / or acquisition with a promising lead being lithium mining for batteries.

Current Tier - OTC Pink Limited

"OTC Markets Group has confirmed that this company has limited disclosure or financial information publicly available, but meets a minimum requirement for public quoting under Rule 15c2-11."

Share Structure - Updated July 20, 2023

Verified Profile - updated at least monthly.

Authorized Shares: 5,000,000,000 [same as in January 2020]

Outstanding Shares: 2,238,709,801 [no change]

Restricted: 219,001,359 [no change]

Unrestricted: 2,019,708,442 [no change]

Note1: It is only the Unrestricted Outstanding Shares count that is relevant to immediate trading. This is relatively low at 2.02B for a stock in the .0006 > .25 price range.

Note 2: There has now been no change to the Unrestricted Outstanding Shares November 2 > July 23 - total 264 days.

Trading Patterns - Previous Business Model - 2021 > November 14, 2022

Note 1: Details of runs in 2019 and 2020 of up to 433% have been deleted - still available to view in the contemporaneous record here.

Note 2: Now that we are expecting runs of 1000% > 2000% in 2023 from current levels, details of 8 x runs less than 84% in 2021 prior to the main move up have been deleted .

2021

Started breakout from .0038 (previous close) > .0050 on January 6, 2021

Ran from .0052 > .0064 on February 9 - 23%

Ran from .0062 > .0080 on February 10 - 29%

Ran from .0073 > .0091 on February 11 - 25%

Ran from .0070 > .0088 on February 18 - 26%

Ran from .0076 > .0091 on March 3 - 20%

Ran from .0086 (previous close) > .0197 (then new 2021 high) on March 24 - 129%

Ran from .0092 (previous close) > .0169 on March 29 on just under 99M traded - 84%

Ran from .0169 (previous close) > .0200 (new 2021 high) on March 30 - 18%

Ran from .0127 (previous close) > .0160 on April 1 on just 28M traded - 26%

Ran from .0098 (previous close ) > .0119 on April 8 - 21%

Ran from .0060 (previous close) > .0117 on July 15 - 95%

Ran from .0018 (days prior) > .0030 by December 14 - 66%

2022

Ran from .0018 > .0024 on February 4 - 33%

Ran from .0008 > .0014 by March 7+8 - 75%

Ran from .0008 (previous close ask) > .0011 on April 22 - 37.5%

Ran from .0009 (previous close ask) > .0012 on April 27 - 33%

Ran from .0007 (available previously) > .0012 on September 7 - 71%

Ran from .0005 (previous close) > .0007 on September 30 - 40%

Trading Patterns - New Business Model - November 15, 2022 Onwards

2022

Ran from .0004 > .0007 on November 15 - 75%

Ran from .0007 > .0010 on November 18 - 43%

2023

Moved up from .0004 > .0005 on February 16 - 25%

Moved up from .0005 > .0006 on March 16 - 20%

Started breakout on July 5, 2023 - undercut ask of 20M at .0005 bought out

Ran from .0005 > .0009 on July 5 - 80%

With confirmation of the CEO change, the 2022 Annual Report filed, WY SOS updates of May 12 and now the Company Profile at otcmarkets.com starting to get updated on June 30, we might well see significant additional buying in the near future and over the next few weeks/months into 2024.

Expect a dramatic move up anytime we get sufficiently large buys set across several successive asks - as happened on November 15 and November 18, 2022.

We should get past any remaining mass 1-tick flippers by .0010 and
get back to a more normal few M per .0001 from .0011 > .0020 then much thinner still after that all the way to the .01>.02+ range IMO based on detailed record keeping over the last few years since $SFLM was last at .02.

As with all my long-term top picks, knowing who got what where - relative to you by process of elimination - is important when deciding the ratio of shares to keep long-term vs locking in partial profits at peaks in the .01 > .02+ range - as is patience - this is a long-term play throughout 2023 and into 2024.

Performance and Outlook

$SFLM will remain a potential top profit pick for me throughout 2023 and into 2024 for self-evident reasons in this Overview.

Performance in each year 2020 > 2022 has shown that it pays to be ready at all times for surges with tradeable lots from multiple price points - not just trying to get the cheapest of the year and stretch them.

Continued large profit trading opportunities are anticipated ahead throughout 2023 and future years for those who maintain a large inventory of shares at a variety of price points. Having plenty of shares - you don't need the cheapest - avoids the need to chase every time it runs.

With some OTC tickers now adding 10 Billion - even 50 Billion - shares per update, $SFLM remains one of the thinnest sub .02 tickers in the OTC with an immediately tradeable Unrestricted Outstanding shares count of only 2.019 Billion unchanged for 264 days as at July 23, 2023.

Cancel any left over ask sell orders at close to get the maximum gap up at each open.

Expect .02+ at some point ahead in 2023 / later years and watch out for the following catalysts:

- Momentum move up ahead of updates through former long-term bidders and new interest taking the small offered asks causing bidders to commit to ask buying while they still can under .0020.

- Update to the Business Description at otcmarkets.com.

- Updates on the "impressive deal flow of prospects that could be acquired or technology that could be licensed by SFLM” [source: PR November 15, 2022]

- Updates on the lithium mining initiative for batteries.

- Updates on acquisitions.

- Possible name change.

- Possible ticker change.

SEC Action Against Actions Of Previous CEO - Matter Now Closed

The SEC had been investigating the old company under the previous CEO for selling unregistered offerings October 10, 2019 up to December 9, 2021. This accounted for why share increases declared monthly at otcmarkets.com during that period appeared to be insignificant compared to the total volume traded in each period. The matter is now closed with $SFLM agreeing to pay a $25K fine in quarterly installments.

SEC notices linked here:

https://www.sec.gov/news/press-release/2023-9...ovdelivery

https://www.sec.gov/litigation/admin/2023/33-11188.pdf

Not a financial advisor - just stating what I'm basing my trading decisions on.

I will be holding some $SFLM in my portfolio throughout 2023 and into 2024 for long-term growth, trading some on surges from the bottom up too and reloading on any dips.



SFLMaven, Inc. (SFLM) Stock Research Links

SFLM Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 50

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 612

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 56

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 351

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 69

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 344

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 84

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading

Top 5 Most Recently Viewed Articles

Equitage Ventures Launches $47.3M Fund for Senior Care Tech

Updated Category News Views 329

Equitage Ventures Launches Significant Investment Fund Equitage Ventures, an early-stage venture capital firm dedicated to AgeTech, has announced the successful final closing of a substantial $47.3 million investment fund. This fund is designed to provide critical capital, distribution resources, and strategic guidance to innovative entrepreneurs who aim to tackle the...

Continue Reading
Understanding Market Trends: Insights into Chevron Corp's Performance

Updated Category News Views 171

Chevron Corp Market Sentiment Analysis Chevron Corp (NYSE: CVX) has experienced a noteworthy decline in its short interest as a percentage of float, showing a 10.26% decrease since its previous report. Currently, there are approximately 14.02 million shares sold short, which accounts for 0.7% of all shares available for trading. Given the trading volume, it is estimated...

Continue Reading
Establishment of Blakely McCrory Hope Fund at Moody Gardens

Updated Category News Views 200

Introducing the Blakely McCrory Hope Fund Moody Gardens is proud to announce a special initiative to honor the memory of a young girl who captured the hearts of many: the Blakely McCrory Hope Fund. This fund has been established in loving memory of 8-year-old Blakely McCrory, who lost her life in a tragic flooding incident that occurred during the summer months....

Continue Reading
Star-Studded Table Read of 'It's a Wonderful Life' Event

Updated Category News Views 221

Exciting Holiday Table Read for a Worthy Cause The Ed Asner Family Center is pulling out all the stops this holiday season with an exciting virtual table read of the beloved classic, "It's a Wonderful Life." Scheduled for December 14 at 5 PM PST, this event promises to spread joy while supporting individuals and families with special needs. Star-Studded Cast Comes...

Continue Reading
Transforming $100 Into Over $1700 with Monolithic Power Systems

Updated Category News Views 145

Understanding the Growth of Monolithic Power Systems Monolithic Power Systems (NASDAQ: MPWR) has showcased impressive financial performance over the past decade, outperforming many market benchmarks. With an impressive annualized growth rate of 19.88%, it has attracted the attention of savvy investors. The Power of Compounded Returns Imagine investing $100 in MPWR stock...

Continue Reading